Combining two hyaluronic acids in osteoarthritis of the knee: A randomized, double-blind, placebo-controlled trial

Clinical Rheumatology

Volumn 27, Issue 8, 2008, Pages 975-981

  Petrella, Robert J ^a,b   Cogliano, Anthony ^a   Decaria, Joseph ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b NONE   (Canada)

Author keywords

Hyaluronic acid; Knee osteoarthritis; Molecular weight composition

Indexed keywords

ANALGESIC AGENT; CYCLOOXYGENASE 2; HIGH MOLECULAR WEIGHT HYALURONIC ACID; HYALURONIC ACID; HYALURONIC ACID DERIVATIVE; LOW MOLECULAR WEIGHT HYALURONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; NUTRACEUTICAL; PARACETAMOL; PLACEBO; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; BRACE; CLINICAL TRIAL; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE SWELLING; JOINT STIFFNESS; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; MONOTHERAPY; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PHYSIOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REST; TREATMENT DURATION; VISUAL ANALOG SCALE; WALKING;

AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYALURONIC ACID; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES; VISCOSUPPLEMENTS;

EID: 47349110693     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0834-4     Document Type: Article

References (21)

1. Dieppe P (1998) Osteoarthritis. Acta Orthop Scand 69(Suppl 281):2-5
2. Balasz EA, Denlinger SL (1993) Viscosupplementation: A new concept in the treatment of osteoarthritis. J Rheumatol 20(Suppl 39):3-9
3. Altman R, Moskowitz R, Felson DT, Anderson JJ (2002) Hyaluronate sodium injections for osteoarthritis: The truth. Arch Intern Med 162:2498-2500
4. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines (2000) Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 43(9):1905-1915
5. Dahlberg L, Lohmander LS, Ryd L (1994) Intraarticular injections of hyaluronan in patients with cartilage abnormalities and knee pain. Arthritis Rheum 37:521-528
6. Dougados M, Nguyen M, Listrat V, Amor B (1993) High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: A 1-year placebo-controlled trial. Osteoarthr Cartil 1:97-103
7. Petrella RJ, DiSilvestro MD, Hildebrand C (2002) Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee. Arch Intern Med 162:292-298
8. Karlsson J, Sjogren LS, Lohmander LS (2002) Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis: A controlled, randomized, double-blind, parallel-design multi-center study. Rheumatology (Oxford) 41:1240-1248
9. Arrol B, Goodyear-Smith F (2004) Corticosteroid injections for osteoarthritis of the knee: Meta-analysis. BMJ 328:869 Epub
10. Leopold SS, Redd BB, Warme WJ, Wehrle PA, Pettis PD, Shott S (2003) Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee: A prospective, randomized trial. J Bone Joint Surg 85:1197-1203
11. Adams ME, Atkinson MH, Lussier AJ et al (1995) The role of viscosupplementation with hylan GF-20 (Synvisc) in the treatment of osteoarthritis of the knee: A Canadian multi-centre trial comparing hylan GF-20 alone, hylan GF-20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthr Cartil 3:213-226
12. Lo GH, LaValley M, McAlindon T, Felson DT (2003) Intraarticular hyaluronic acid in the treatment of knee osteoarthritis: A meta-analysis. JAMA 290:3115-3121
13. Mamlin LA, Melfi CA, Parchman ML et al (1998) Management of osteoarthritis of the knee by primary care physicians. Arch Fam Med 7:563-567
14. Kotevoglu N, Iyibozkurt PC, Hiz O, Toktas H, Kuran B (2006) A prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis. Rheumatol Int 26:325-330
15. Kirchener M, Marshall D (2006) A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee. Osteoarthr Cartil 14:154-162
16. Greenberg DD, Stoker A, Kane S, Cockrell M, Cook JL (2006) Biochemical effects of two different hyaluronic acid products in a co-culture model of osteoarthritis. Osteoarthr Cartil 14:814-822
17. Altman RD, Fries JF, Block DA et al (1987) Radiographic assessment of progression in osteoarthritis. Arthritis Rheum 30:1214-1225
18. Bellamy N (1997) Osteoarthritis clinical trials: Candidate variables and clinimetric properties. J Rheumatol 24:768-778
19. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I (1996) Improving the quality of reporting clinical trials: The CONSORT statement. JAMA 276:637-639
20. Murakami T, Salai N, Sawae Y, Tanaka K, Ihara M (2004) Influence of proteoglycan on time-dependent mechanical behaviors of articular cartilage under constant total compressive deformation. JSME Int J 47:1049-1055
21. Ghosh P, Guidolin D (2002) Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: Are the effects of molecular weight dependent? Semin Arthritis Rheum 32:10-37